The role of neoadjuvant therapy in surgically resectable esophageal cancer

Archives of Surgery

Volumn 131, Issue 8, 1996, Pages 819-825

  Swisher, Stephen G ^a,b,e   Holmes, E Carmack ^a   Hunt, Kelly K ^a,b   Doty, Jeffrey E ^a,d   Zinner, Michael J ^a,c   McFadden, David W ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Good Samaritan Hospital San Jose   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER SURVIVAL; CONFERENCE PAPER; ESOPHAGUS CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0029747153     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430200029005     Document Type: Conference Paper

References (11)

1. DeMeester TR, Barlow AP. Surgery and current management for cancer of the esophagus and cardia. Curr Probl Surg. 1988;25:477-531.
2. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990;77:845-857.
3. Fahn H-J, Wang L-S, Huang B-S, Huang M-H, Chien K-Y. Tumor recurrence In long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg. 1994;57:677-681.
4. Forastiere AA, Orringer MB, Perez-Tarnayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncology. 1993;11:1118-1123.
5. Naunheim KS, Petruska PJ, Roy TS, et al. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg. 1992;103: 887-895.
6. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1988;96:242-248.
7. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA, Duhaylongsod FG. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg. 1993;105:749-756.
8. Mandard A-M, Dalibard F, Mandard J-C, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer. 1994;73:2680-2686.
9. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
10. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg. 1992;127:1446-1450.
11. Wu GS, El-Deiry W. Apoptotic death of tumor cells correlates with chemosensitivity of p53 or bcl-2. Clin Cancer Res. 1996;2:623-633.